Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03761615 · ClinicalTrials.gov registry record
Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy
A clinical trial, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- 25
- Enrollment target
NCT03761615 is a clinical trial that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 25 participants.
The verdict
NCT03761615 has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The overall goal of this study is to enroll pregnant women with type 1 diabetes and follow their glycemic outcomes prospectively throughout pregnancy and into the post-partum period. The investigators anticipate that when compared to subjects using an Artificial pancreas system (AP) as part of a future protocol, this comparator group of subjects undergoing usual care will exhibit less time in target continuous glucose monitoring (CGM) glucose range defined as 63-140 mg/dL and an increased duration of hypoglycemia with CGM glucose \<63 mg/dL.
Interventions
- DEVICE Dexcom G6 CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-11-13 |
| Est. Completion | 2021-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03761615
The ClinicalTrials.gov registry entry for NCT03761615 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G6 CGM is the first listed.
NCT03761615 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03761615 about?
NCT03761615 is a clinical study titled "Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy". The overall goal of this study is to enroll pregnant women with type 1 diabetes and follow their glycemic outcomes prospectively throughout pregnancy and into the post-partum period. The investigators anticipate that when compared to subjects using an Artificial pancreas system (AP) as part of a fut...
What is the current status of trial NCT03761615?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-11-13. Estimated completion is 2021-06-09.
What interventions are being tested in trial NCT03761615?
The interventions under investigation include: Dexcom G6 CGM (DEVICE).
Who is sponsoring clinical trial NCT03761615?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.